Senhance® for TEP Hernioplasty

About Asensus Surgical

Asensus Surgical is revolutionizing minimally invasive surgery by developing and commercializing the Senhance® Surgical System, a robotic platform integrated with the first globally approved intra-operative augmented intelligence system. The company focuses on reducing surgical variability, improving surgeon ergonomics, and increasing accessibility through reusable instruments and a lower-cost model. Following its acquisition by KARL STORZ, Asensus is positioned to accelerate the global adoption of its digital surgery technology, aiming to set a new standard of care in robotic-assisted procedures.

Therapeutic Areas